...
首页> 外文期刊>Journal of neurology >Sporadic transthyretin amyloidosis with a novel TTR gene mutation misdiagnosed as primary amyloidosis
【24h】

Sporadic transthyretin amyloidosis with a novel TTR gene mutation misdiagnosed as primary amyloidosis

机译:散发性运甲状腺素蛋白淀粉样变性病,其新的TTR基因突变被误诊为原发性淀粉样变性病

获取原文
获取原文并翻译 | 示例
           

摘要

Light-chain amyloidosis [1] is a rare disease caused by a clonal plasma cell dyscrasia associated with multiorgan deposition of amyloidogenic immunoglobulin light chains. Autosomal dominant transthyretin amyloidosis (ATTR) is an even rarer disorder caused by amyloidogenic mutant alleles of TTR manifesting with progressive and fatal involvement of the peripheral nerves, ganglia, heart, kidney, and eyes. The specific therapy is orthotopic liver transplantation [2]. ATTR may be overlooked because of phenotypical variability [3], and also misdiagnosed as AL because of possible coexistence of monoclonal gammopa-thy and limited sensitivity/specificity of light chain immunostaining of biopsy specimens [4, 5].
机译:轻链淀粉样变性病[1]是一种罕见的疾病,是由与淀粉样蛋白生成的免疫球蛋白轻链的多器官沉积有关的克隆性浆细胞发育不良引起的。常染色体显性遗传运甲状腺素蛋白淀粉样变性病(ATTR)是由TTR的淀粉样变性突变等位基因引起的一种更为罕见的疾病,表现为周围神经,神经节,心脏,肾脏和眼睛进行性和致命性侵袭。具体疗法是原位肝移植[2]。由于表型变异性,ATTR可能会被忽略[3],并且由于单克隆γ-半乳糖凝乳酶可能并存,并且活检样本的轻链免疫染色的敏感性/特异性有限,可能会被误诊为AL [4,5]。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号